Publicacions en què col·labora amb Antonio Pérez Martínez (12)

2024

  1. Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience

    Frontiers in Immunology, Vol. 15

2023

  1. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure

    Transplantation and Cellular Therapy, Vol. 29, Núm. 10, pp. 621.e1-621.e6

  2. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

    Frontiers in Pediatrics, Vol. 11

  3. Looking Towards 2030: Strengthening the Environmental Health in Childhood–Adolescent Cancer Survivor Programs

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 1

  4. Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

    Transplantation and Cellular Therapy, Vol. 29, Núm. 11, pp. 702.e1-702.e11

2022

  1. Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH)

    Medicina Clinica, Vol. 159, Núm. 9, pp. 411-419

2021

  1. Haploidentical transplantation in pediatric non-malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH)

    European Journal of Haematology, Vol. 106, Núm. 2, pp. 196-204

  2. Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 5, pp. 328-337.e1

2020

  1. Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)

    American Journal of Hematology, Vol. 95, Núm. 1, pp. 28-37

  2. Immunotherapy with CAR-T cells in paediatric haematology-oncology

    Anales de Pediatria, Vol. 93, Núm. 1, pp. 59.e1-59.e10

  3. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

    Frontiers in Pediatrics, Vol. 8

  4. Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

    BMJ Open, Vol. 10, Núm. 1